[Rituximab (antiCD20 monoclonal antibody) and molecular-biological negativity in the treatment of patients with follicular lymphoma--a way to a cure?--Editorial]
- PMID: 18072423
[Rituximab (antiCD20 monoclonal antibody) and molecular-biological negativity in the treatment of patients with follicular lymphoma--a way to a cure?--Editorial]
Comment on
-
[Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].Vnitr Lek. 2007 Oct;53(10):1057-63. Vnitr Lek. 2007. PMID: 18072430 Czech.